AJP - Gastrointestinal and Liver Physiology, Vol 271, Issue 6 1017-G1027, Copyright © 1996 by American Physiological Society

ARTICLES

Tachykinin-induced increase in gastric mucosal resistance: role of primary afferent neurons, CGRP, and NO

T. Stroff, S. Plate, J. S. Ebrahim, K. H. Ehrlich, M. Respondek and B. M. Peskar
Department of Experimental Clinical Medicine, Ruhr-University of Bochum, Germany.

The tachykinins [Ala5,beta-Ala8]neurokinin A-(4-10) -[Ala5,beta-Ala8]NKA-(4-10) inverted question mark and NKA-(4-10) dose dependently protected against ethanol-induced gastric mucosal damage in rats (half-maximal inhibitory dose, 46 and 48 nmol/kg, respectively). These effects were abolished by primary afferent nerve denervation, calcitonin gene-related peptide (CGRP) immunoneutralization, the CGRP receptor antagonist human (h) hCGRP-(8-37), and inhibition of nitric oxide (NO) biosynthesis by NG-nitro-L-arginine methyl ester. Tachykinin-induced protection occurred despite marked depression of gastric mucosal blood flow and was not associated with increased acid secretion. NK2-receptor blockade antagonized the protective effects of [Ala5,beta-Ala8]NKA-(4-10) and NKA-(4-10), whereas NK1-receptor blockade was ineffective. Blockade of NK2 but not NK1 receptors prevented by 65% the protection evoked by topical capsaicin without affecting capsaicin-induced hyperemia. We conclude that the increase in gastric mucosal resistance evoked by tachykinins is NK2 receptor-mediated and involves primary afferent neurons, CGRP, and NO. Gastric mucosal hyperemia and increased acid secretion do not participate in the effect. Tachykinins activating NK2 receptors contribute to the increase in gastric mucosal resistance but not the increment in mucosal blood flow after primary afferent nerve stimulation by capsaicin.

This article has been cited by other articles:

				K. Takeuchi, S. Kato, M. Takeeda, Y. Ogawa, M. Nakashima, and M. Matsumoto Facilitation by Endogenous Prostaglandins of Capsaicin-Induced Gastric Protection in Rodents through EP2 and IP Receptors J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 1055 - 1062. [Abstract] [Full Text] [PDF]

				B. M. Peskar, K. Ehrlich, and B. A. Peskar Role of ATP-Sensitive Potassium Channels in Prostaglandin-Mediated Gastroprotection in the Rat J. Pharmacol. Exp. Ther., June 1, 2002; 301(3): 969 - 974. [Abstract] [Full Text] [PDF]

				P Holzer Local microcirculatory reflexes and afferent signalling in response to gastric acid challenge Gut, December 1, 2000; 47(90004): iv46 - 48. [Full Text] [PDF]

				A. Rydning, O. Lyng, S. Aase, and J. E. Gronbech Substance P may attenuate gastric hyperemia by a mast cell-dependent mechanism in the damaged gastric mucosa Am J Physiol Gastrointest Liver Physiol, November 1, 1999; 277(5): G1064 - G1073. [Abstract] [Full Text] [PDF]

				P. Holzer and M. A. Pabst Visceral Afferent Neurons: Role in Gastric Mucosal Protection Physiology, October 1, 1999; 14(5): 201 - 206. [Abstract] [Full Text] [PDF]

				K. Ehrlich, S. Plate, T. Stroff, B. Gretzer, M. Respondek, and B. M. Peskar Peptidergic and cholinergic neurons and mediators in peptone-induced gastroprotection: role of cyclooxygenase-2 Am J Physiol Gastrointest Liver Physiol, May 1, 1998; 274(5): G955 - G964. [Abstract] [Full Text] [PDF]

				I. Th. Lippe, C. H. Wachter, and P. Holzer J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1294 - 1302. [Abstract] [Full Text]